[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2005501097A - 膨張可能な胃内滞留装置 - Google Patents

膨張可能な胃内滞留装置 Download PDF

Info

Publication number
JP2005501097A
JP2005501097A JP2003520705A JP2003520705A JP2005501097A JP 2005501097 A JP2005501097 A JP 2005501097A JP 2003520705 A JP2003520705 A JP 2003520705A JP 2003520705 A JP2003520705 A JP 2003520705A JP 2005501097 A JP2005501097 A JP 2005501097A
Authority
JP
Japan
Prior art keywords
retention device
gastric retention
drug
gastric
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003520705A
Other languages
English (en)
Japanese (ja)
Inventor
ジェイムズ ダブリュ． アイレス
Original Assignee
ザ ステイト オブ オレゴン アクティング バイ アンド スルー ザ ステイト ボード オブ ハイアー エデュケイション、 オン ビハーフ オブ オレゴン ステイト ユニバーシティー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ ステイト オブ オレゴン アクティング バイ アンド スルー ザ ステイト ボード オブ ハイアー エデュケイション、 オン ビハーフ オブ オレゴン ステイト ユニバーシティー filed Critical ザ ステイト オブ オレゴン アクティング バイ アンド スルー ザ ステイト ボード オブ ハイアー エデュケイション、 オン ビハーフ オブ オレゴン ステイト ユニバーシティー
Publication of JP2005501097A publication Critical patent/JP2005501097A/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2003520705A 2001-08-16 2001-10-22 膨張可能な胃内滞留装置 Withdrawn JP2005501097A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31307801P 2001-08-16 2001-08-16
PCT/US2001/046146 WO2003015745A1 (en) 2001-08-16 2001-10-22 Expandable gastric retention device

Publications (1)

Publication Number Publication Date
JP2005501097A true JP2005501097A (ja) 2005-01-13

Family

ID=23214285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003520705A Withdrawn JP2005501097A (ja) 2001-08-16 2001-10-22 膨張可能な胃内滞留装置

Country Status (14)

Country Link
EP (1) EP1416914A1 (de)
JP (1) JP2005501097A (de)
KR (1) KR20040032918A (de)
CN (1) CN1543337A (de)
BR (1) BR0117123A (de)
CA (1) CA2456976A1 (de)
CO (1) CO5670360A2 (de)
IL (1) IL160363A0 (de)
MX (1) MXPA04001388A (de)
NO (1) NO20040611L (de)
NZ (1) NZ531461A (de)
PL (1) PL368327A1 (de)
WO (1) WO2003015745A1 (de)
ZA (1) ZA200402066B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005510531A (ja) * 2001-11-21 2005-04-21 イー−ゼット−イーエム，インク． 医学的処置および診断的処置において使用される配合物
JP2009543886A (ja) * 2006-07-19 2009-12-10 スミスクライン・ビーチャム・コーポレイション ガンマシンチグラフィー評価のために処方物を放射性標識する方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1701705A4 (de) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp Verbesserte absorption von dosierformen mit modifizierter freisetzung
US7785291B2 (en) 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
CN102552103B (zh) * 2010-12-20 2013-11-20 西安力邦医药科技有限责任公司 拉米夫定固体分散体、其制备方法、药物组合物和用途
US10507127B2 (en) 2012-06-07 2019-12-17 Epitomee Medical Ltd. Expandable device
EP3091962B1 (de) 2013-12-05 2022-06-08 Epitomee Medical Ltd. Rückhaltevorrichtungen und systeme zur in-situ-freisetzung von pharmazeutischen wirkstoffen
CN106573015B (zh) 2014-06-11 2021-11-26 麻省理工学院 肠溶弹性体
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
WO2016178971A1 (en) 2015-05-01 2016-11-10 Massachusetts Institute Of Technology Triggerable shape memory induction devices
EP3364946A4 (de) 2015-10-23 2019-06-26 Lyndra, Inc. Magenverweilsysteme zur verzögerten freisetzung von therapeutischen wirkstoffen und verfahren zu deren verwendung
BR112018011636B1 (pt) 2015-12-08 2024-03-12 Lyndra Therapeutics, Inc Sistema de residência gástrico para liberação sustentada de um agente terapêutico
EP3463313A4 (de) 2016-05-27 2019-12-18 Lyndra, Inc. Materialarchitektur für magenverweilsysteme
CA3038557A1 (en) 2016-09-30 2018-04-05 Lyndra, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
TWI811221B (zh) 2017-06-09 2023-08-11 美商萊恩卓治療公司 具有釋放速率調節膜之胃的滯留系統
WO2019126218A1 (en) * 2017-12-18 2019-06-27 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
TR201914116A2 (tr) * 2019-09-17 2021-04-21 Univ Yeditepe Doğal bi̇yomateryaller i̇le kri̇yojelleri̇n üreti̇m yöntemi̇ ve bu kri̇yojelleri̇n yumuşak doku i̇skelesi̇ veya i̇laç taşiyici si̇stem olarak kullanimi
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
ATE285226T1 (de) * 1997-08-11 2005-01-15 Alza Corp Gastrische zurückhalteform zur verlängerten freisetzung eines wirkstoffs
EP1281397A1 (de) * 1998-09-14 2003-02-05 Ranbaxy Laboratories Limited Oral verabreichtes System zur zeitlich und räumlich gesteuerten Arzneistoffabgabe
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
AU2001268722B8 (en) * 2000-06-23 2005-09-29 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005510531A (ja) * 2001-11-21 2005-04-21 イー−ゼット−イーエム，インク． 医学的処置および診断的処置において使用される配合物
JP4820054B2 (ja) * 2001-11-21 2011-11-24 ブラッコ ディアグノスティックス，インク． 医学的処置および診断的処置において使用される配合物
JP2009543886A (ja) * 2006-07-19 2009-12-10 スミスクライン・ビーチャム・コーポレイション ガンマシンチグラフィー評価のために処方物を放射性標識する方法

Also Published As

Publication number Publication date
CO5670360A2 (es) 2006-08-31
ZA200402066B (en) 2005-05-09
WO2003015745A1 (en) 2003-02-27
NZ531461A (en) 2008-03-28
EP1416914A1 (de) 2004-05-12
IL160363A0 (en) 2004-07-25
BR0117123A (pt) 2004-09-28
MXPA04001388A (es) 2004-05-27
KR20040032918A (ko) 2004-04-17
CN1543337A (zh) 2004-11-03
NO20040611L (no) 2004-04-16
PL368327A1 (en) 2005-03-21
CA2456976A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
US20040219186A1 (en) Expandable gastric retention device
Shaha et al. An overview of a gastro-retentive floating drug delivery system
Streubel et al. Drug delivery to the upper small intestine window using gastroretentive technologies
Prajapati et al. Raft forming system—An upcoming approach of gastroretentive drug delivery system
JP2005501097A (ja) 膨張可能な胃内滞留装置
Streubel et al. Gastroretentive drug delivery systems
Gopalakrishnan et al. Floating drug delivery systems: A Review
Kotreka et al. Gastroretentive floating drug-delivery systems: a critical review
Ishak Buoyancy-generating agents for stomach-specific drug delivery: an overview with special emphasis on floating behavior
JP2002533380A (ja) 多孔性粒子を含む剤形
Sathish et al. Floating drug delivery systems for prolonging gastric residence time: a review
WO2007106957A1 (en) Multiple units controlled-release floating dosage forms
Vasave A REVIEW ON: FLOATING DRUG DELIVERY SYSTEM
US20240299304A1 (en) A method for the production of gastroretentive compact matrices for the controlled release of active substances and compact matrices thus obtained
Tekade et al. A comprehnsive review ongastro-retentive drug delivery system
Jaimini et al. A review on formulation and evaluation of gastroretentive floating tablet of Nifedipin
Chaudhary et al. Recent Development in Floating Drug Delivery System: An Overview
Kandwal et al. Floating drug delivery system: A novel approach
Janhavi et al. A Comprehensive Review on Gastro-Retentive Floating Drug Delivery Systems
Katakam et al. Floating drug delivery systems: a review
Choudhary et al. A Review: Gastro Retentive Drug Delivery System
AU2002225872A1 (en) Expandable gastric retention device
Mujoriya et al. A Overview on Study of Floating Drug Delivery Systems
Singh et al. Gastroretentive Delivery
Omidian et al. Oral targeted drug delivery systems: gastric retention devices

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041007

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20050502

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20081006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20081006